Searched for
CRO BUSINESS
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
ServiceNow names ex-SAP exec Kulmeet Bawa as India & SAARC MD, GVPHe takes the helm from Ganesh Lakshminarayanan, who has moved to Tata Communications. Lakshminarayanan had joined the firm as the India and...
Donald Trump company to own Cryptocurrency token CRO. What we know so farDonald Trump Media said it plans to purchase $105 million worth of CRO. Yorkville said the total expected funding for the company's treasur...
Mahindra Finance appoints Mahesh Rajaraman as CROMahindra & Mahindra Financial Services appoints Mahesh Rajaraman as Chief Risk Officer, replacing Mallika Mittal who resigned amid a fraud ...
RBI prescribes qualifications for MDs, WTDs of urban cooperative banksIt further said the MD/WTD should be a post graduate or have qualifications in finance discipline. He or she could be either chartered/cost...
Axis Bank appoints Amit Talgeri as Chief Risk OfficerNaveen Tahilyani has been appointed as Group Executive -- Head Banking Operations and Transformation -- with effective from January 6. Cyri...
RBI asks NBFCs to appoint chief risk officersRegulator says CRO should not have reporting relationship with business verticals of companies.
NBFCs with asset size of Rs 5,000 crore must have chief risk officers: RBIThe CRO is required to function independently so as to ensure highest standards of risk management.
RBI tells bigger NBFCs to appoint chief risk officerThe CRO "is required to function independently to ensure highest standards of risk management", a release said.
Delay in approvals unacceptable: Gujarat CROsAny delay in approvals will be a violation of "Right to Life guaranteed by the Constitution" says Gujarat's CROs.
- Global pharma companies' research widens scope for entrepreneurs
India is a favourite clinical trials destination. The CRO business grew 84% during 2006-2008 as against the global average of 12%.
- KKN Group forays into steel biz
The Rs450-croRs KKN Group of companies, which has a preence in edible oils through the Tripti and Sunshine brands, has diversified into the...
- Cipla gets board nod to buy Meditab for Rs133 cr
Drug major Cipla said it would acquire domestic pharma company Meditab Specialties for Rs133.35 croRs and it also announced a special divid...
- Jubilant hunts for buys abroad
Jubilant Organosys is evaluating various proposals to acquire companies in the contract research and manufacturing services (CRAMS), drug d...
- Clinical research outsourcing yet to take off
Despite the leap-frogging growth projections for the healthcare-linked business, lack of awareness, infrastructure bottleneck and crunch in...
- Manpower crunch, lack of awareness affect CRO
Clinical research outsourcing (CRO), touted as the next big think on the outsourcing sphere, is yet to take off.
- Actavis acquires Sanmar subsidiary
Actavis Group, the global generic pharma company, has announced the acquisition of the Active Pharmaceutical Ingredient (API).